Literature DB >> 15224227

[Unusual complication of silicon synovitis in the rheumatoid wrist].

B Siemon1, T Schubert, J Grifka, N Borisch.   

Abstract

Silicone synovitis is an important clinical entity recognized in rheumatoid patients after arthroplasties with silicone implants. It is a foreign body reaction to particulate material (silicone elastomer) characterized clinically by the re-occurrence of pain, stiffness and swelling at the site of arthroplasty after initial relief of symptoms. Whereas silicone synovitis is a rare complication in metacarpophalangeal implants, it is an important one in the wrist implant. Long-term follow-up studies have revealed that the rates of fracture and subsidence are high and that the implants deteriorate with time necessitating operative revisions in up to 50% of cases. Indications should therefore be restricted to a painful wrist in the elderly, very low demand patient with insufficient bone stock to permit total wrist arthroplasty with a metal-on-plastic design. Severe preoperative deformity and the need for use of ambulatory aids may further limit the indication. The unusual case of direct perforation of silicone particles from the wrist into the tendon sheath of the M. flexor pollicis longus inducing a tumor-like synovitis and a secondary carpal tunnel syndrome is presented. The importance of silicone synovitis and the indication at present for implantation of a silicone wrist spacer in the rheumatoid patient are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224227     DOI: 10.1007/s00393-004-0564-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  2 in total

Review 1.  [Rheumatic tendon pathologies].

Authors:  M Thomas; M Jordan
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

2.  [Histopathological particle algorithm. Particle identification in the synovia and the SLIM].

Authors:  V Krenn; P Thomas; M Thomsen; J P Kretzer; S Usbeck; L Scheuber; G Perino; W Rüther; R v Welser; F Hopf; M Huber
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.